← Back to Search

Other

Stevia for Childhood Obesity

N/A
Recruiting
Research Sponsored by Arkansas Children's Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Excessive weight: BMI percentile ≥ 85th and <140% of the 95th percentile or BMI ≥35 to <40 kg/m2
Age 8-12 years
Must not have
Chronic kidney disease
Children with class 3 obesity (i.e., BMI ≥ 140% of the 95th percentile or BMI ≥ 40.0 kg/m2)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 to 14 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if stevia can help kids 8-12 manage their weight and metabolism better than other sugar substitutes or water.

Who is the study for?
The Sweet Kids Study is for children aged 8-12 who regularly drink sugary beverages and are either of normal weight or overweight, but not severely obese. They should be willing to try new drinks and not have conditions like diabetes, chronic infections, hormonal diseases, severe asthma, bleeding disorders, certain mental health issues or a recent history of antibiotic use.
What is being tested?
This study compares the effects of three types of beverages on children's weight and metabolic function over an 8 to14-week period: water flavored without calories, drinks sweetened with stevia (a no-calorie sweetener), and drinks sweetened with regular sugar (sucrose).
What are the potential side effects?
While the trial does not specifically list side effects related to the beverages being tested (water, stevia-sweetened beverage, sucrose-sweetened beverage), potential concerns may include digestive changes due to different sweeteners or reactions in kids sensitive to taste changes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My BMI is high, between 35 and less than 40, or it's in the top 15% for my age.
Select...
I am between 8 and 12 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have chronic kidney disease.
Select...
My child is classified with class 3 obesity.
Select...
I have asthma triggered by exercise.
Select...
I have been diagnosed with type 1 or type 2 diabetes.
Select...
I do not have chronic infections like HIV or hepatitis.
Select...
I have epilepsy.
Select...
I have a bleeding disorder like hemophilia.
Select...
I have an autoimmune disease like lupus or thyroiditis.
Select...
I use my asthma inhaler daily to control my severe asthma.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 to 14 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 to 14 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Body mass index (BMI) z-scores
Fat mass index z-scores
Secondary study objectives
Blood pressure percentiles
Fasting plasma triglycerides
Glucose management index
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Stevia sweetened beverageExperimental Treatment1 Intervention
The stevia-sweetened beverage contains 30.1 mg of steviol equivalents. Participants will be asked to consume the study product once a day for 8 to 14 weeks if they have normal weight or excessive weight, respectively.
Group II: Calorie free flavored water beverageActive Control1 Intervention
Flavored water. Participants will be asked to consume the study product once a day for 8 to 14 weeks if they have normal weight or excessive weight, respectively.
Group III: Sucrose sweetened beverageActive Control1 Intervention
Sucrose (i.e. sugar): 25 g sugar (100 Kcal per serving). Participants will be asked to consume the study product once a day for 8 to 14 weeks if they have normal weight or excessive weight, respectively.

Find a Location

Who is running the clinical trial?

CargillIndustry Sponsor
27 Previous Clinical Trials
3,021 Total Patients Enrolled
5 Trials studying Obesity
1,402 Patients Enrolled for Obesity
Arkansas Children's Hospital Research InstituteLead Sponsor
138 Previous Clinical Trials
5,025,406 Total Patients Enrolled
7 Trials studying Obesity
4,781 Patients Enrolled for Obesity

Media Library

Calorie free flavored water beverage (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05992688 — N/A
Obesity Research Study Groups: Calorie free flavored water beverage, Sucrose sweetened beverage, Stevia sweetened beverage
Obesity Clinical Trial 2023: Calorie free flavored water beverage Highlights & Side Effects. Trial Name: NCT05992688 — N/A
Calorie free flavored water beverage (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05992688 — N/A
~84 spots leftby Oct 2025